DR | Doxorubicin |
EV | Empty vector |
MOMP | Mitochondrial outer membrane permeabilization |
PGCCs | Polyploid giant cancer cells |
SASP | Senescence-associated secretory phenotype |
TIS | Therapy-induced senescence |
TNBC | Triple-negative breast cancer |
DR | Doxorubicin |
EV | Empty vector |
MOMP | Mitochondrial outer membrane permeabilization |
PGCCs | Polyploid giant cancer cells |
SASP | Senescence-associated secretory phenotype |
TIS | Therapy-induced senescence |
TNBC | Triple-negative breast cancer |